{
    "disease": "Other specified acute viral hepatitis",
    "icd_code": "B178",
    "parameters": {
        "symptoms": [
            {
                "name": "Jaundice",
                "severity": "Variable, can be severe",
                "pattern": "Present in a significant portion of cases (e.g., 68.8% in one study)"
            },
            {
                "name": "Vomiting",
                "severity": "Variable",
                "pattern": "Present in a significant portion of cases (e.g., 57.6% in one study)"
            },
            {
                "name": "Abdominal pain",
                "severity": "Variable",
                "pattern": "Present in a portion of cases (e.g., 36.1% in one study), can lead to hospitalization"
            },
            {
                "name": "Nausea",
                "severity": "Variable",
                "pattern": "Present in a portion of cases (e.g., 25.7% in one study)"
            },
            {
                "name": "Gastrointestinal symptoms",
                "severity": "Variable",
                "pattern": "Commonly reported"
            },
            {
                "name": "General weakness",
                "severity": "Variable",
                "pattern": "Commonly reported"
            },
            {
                "name": "Diarrhea",
                "severity": "Variable",
                "pattern": "Can lead to hospitalization"
            },
            {
                "name": "Encephalopathy",
                "severity": "Severe",
                "pattern": "Rarely reported"
            }
        ],
        "reversion": "1",
        "vital_signs": {
            "description": "Not explicitly detailed in provided text, but abnormal liver function tests are a key indicator."
        },
        "physical_findings": [
            "Jaundice"
        ],
        "lab_values": {
            "AST": {
                "abnormal_range": ">500 IU/L (in some studies, used as a diagnostic criterion)"
            },
            "ALT": {
                "abnormal_range": ">500 IU/L (in some studies, used as a diagnostic criterion)"
            },
            "Total Bilirubin": {
                "abnormal_range": "Elevated in many cases"
            }
        },
        "risk_factors": [
            "Adenovirus infection (particularly adenovirus type 41 species F)",
            "SARS-CoV-2 infection (potential role in priming the immune system for subsequent liver damage)"
        ],
        "imaging_findings": {}
    },
    "diagnostic_criteria": {
        "required": [
            "Acute hepatitis (non-hepatitis A-E)",
            "AST or ALT > 500 IU/L (in some studies)"
        ],
        "supportive": [
            "Negative testing for hepatitis A, B, C, and E viruses",
            "Positive testing for adenovirus (especially Ad-F41) or SARS-CoV-2"
        ]
    },
    "differential_diagnoses": [
        "Hepatitis A",
        "Hepatitis B",
        "Hepatitis C",
        "Hepatitis E",
        "Other viral infections",
        "Autoimmune hepatitis",
        "Drug-induced liver injury"
    ]
}